Related content

A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer: Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor

By Ostheimer C.   Bache M.   Güttler A.   Kotzsch M.   Vordermark D.  

Strahlentherapie und Onkologie, Vol. 190, Iss. 3, 2014-03 ,pp. : 276-282

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Factors Relating to Tumor Recurrence and Survival after Resection of Lung Cancer

By Kim Eun Soo   Lee In Jae   Bae Young-A   Lee Jae-Woong   Im Hyoung June   Jeon Yong Hwan  

Acta Radiologica, Vol. 50, Iss. 8, 2009-01 ,pp. : 876-883

Blackwell Publishing

Access to resources Recommend Favorite

Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer

By Oorschot B.   Assenbrunner B.   Schuler M.   Beckmann G.   Flentje M.  

Strahlentherapie und Onkologie, Vol. 190, Iss. 3, 2014-03 ,pp. : 270-275

Springer Publishing Company

Access to resources Recommend Favorite

Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: A retrospective analysis of 303 patients

By Rief H.   Muley T.   Bruckner T.   Welzel T.   Rieken S.   Bischof M.   Lindel K.   Combs S.E.   Debus J.  

Strahlentherapie und Onkologie, Vol. 190, Iss. 1, 2014-01 ,pp. : 59-63

Springer Publishing Company

Access to resources Recommend Favorite

Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy

By Hamamoto Yasushi  

Japanese Journal of Radiology, Vol. 30, Iss. 3, 2012-04 ,pp. : 249-254

Springer Publishing Company

Access to resources Recommend Favorite